Published in Cancer Res on February 15, 1987
Human bronchus and intestine express the same mucin gene. J Clin Invest (1991) 1.23
Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells. Proc Natl Acad Sci U S A (1988) 0.80
Torsional tension in the DNA double helix measured with trimethylpsoralen in living E. coli cells: analogous measurements in insect and human cells. Cell (1980) 4.42
The folded genome of Escherichia coli isolated in a protein-DNA-RNA complex. Proc Natl Acad Sci U S A (1971) 4.32
RNA molecules bound to the folded bacterial genome stabilize DNA folds and segregate domains of supercoiling. Cold Spring Harb Symp Quant Biol (1974) 3.57
Fuel ethanol production from lignocellulose: a challenge for metabolic engineering and process integration. Appl Microbiol Biotechnol (2001) 3.27
Interaction of the Escherichia coli HU protein with DNA. Evidence for formation of nucleosome-like structures with altered DNA helical pitch. J Mol Biol (1986) 3.03
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem (1991) 2.68
Chromosomes in living Escherichia coli cells are segregated into domains of supercoiling. Proc Natl Acad Sci U S A (1981) 2.67
High-burst-strength, feedback-controlled bipolar vessel sealing. Surg Endosc (1998) 2.59
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A (1980) 2.35
Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell. Cell (1980) 2.33
Science and government. Navigating the anthropocene: improving Earth system governance. Science (2012) 2.19
Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. Proc Natl Acad Sci U S A (1981) 2.13
DNA ring closure mediated by protein HU. J Biol Chem (1989) 2.09
Perfect palindromic lac operator DNA sequence exists as a stable cruciform structure in supercoiled DNA in vitro but not in vivo. Proc Natl Acad Sci U S A (1983) 2.01
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol (1989) 1.93
Increasing NADH oxidation reduces overflow metabolism in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2007) 1.89
Metabolic engineering of Saccharomyces cerevisiae. Microbiol Mol Biol Rev (2000) 1.82
Supercoils in prokaryotic DNA restrained in vivo. Proc Natl Acad Sci U S A (1980) 1.79
Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res (1990) 1.72
Synthesis of ribosomal RNA on a protein-DNA complex isolated from bacteria: a comparison of ribosomal RNA synthesis in vitro and in vivo. J Mol Biol (1970) 1.67
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol (1994) 1.65
Prokaryotic DNA in nucleoid structure. CRC Crit Rev Biochem (1976) 1.63
Structure and properties of the bacterial nucleoid. Cell (1982) 1.59
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res (1994) 1.55
Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem (1992) 1.55
Chain termination of ribosomal RNA synthesis in vitro. Nature (1970) 1.53
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem (1990) 1.52
Tandem synthesis of the 16S and 23S ribosomal RNA sequences of Escherichia coli. Nat New Biol (1971) 1.45
Oxygen and glucose consumption related to Na+-K+ transport in canine brain. Stroke (1982) 1.45
The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc Natl Acad Sci U S A (1986) 1.44
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem (1990) 1.43
Altered DNA ligase III activity in the CHO EM9 mutant. Mutat Res (1994) 1.42
Cruciform transitions in DNA. J Biol Chem (1984) 1.41
Redistribution of the nuclear mitotic apparatus protein (NuMA) during mitosis and nuclear assembly. Properties of purified NuMA protein. Exp Cell Res (1986) 1.39
Glucose control in Saccharomyces cerevisiae: the role of Mig1 in metabolic functions. Microbiology (1998) 1.37
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem (1992) 1.29
Size and DNA content of purfied E. coli nucleoids observed by fluorencence microscopy. Nature (1975) 1.28
Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network. Nat Biotechnol (2000) 1.27
Cost analysis of ethanol production from willow using recombinant Escherichia coli. Biotechnol Prog (1994) 1.26
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem (1997) 1.26
Potential inhibitors from wet oxidation of wheat straw and their effect on ethanol production of Saccharomyces cerevisiae: wet oxidation and fermentation by yeast. Biotechnol Bioeng (2003) 1.25
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25
Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int (1996) 1.24
Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res (1993) 1.22
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res (1995) 1.19
Polyamines stabilise DNA folds. Nature (1975) 1.19
Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur J Biochem (1997) 1.16
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res (1997) 1.14
Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem J (1995) 1.11
Simultaneous overexpression of enzymes of the lower part of glycolysis can enhance the fermentative capacity of Saccharomyces cerevisiae. Yeast (2000) 1.10
Repair replication of DNA in vivo. Cold Spring Harb Symp Quant Biol (1968) 1.10
NuMA protein is a human autoantigen. Arthritis Rheum (1984) 1.10
Interactions stabilizing DNA tertiary structure in the Escherichia coli chromosome investigated with ionizing radiation. Chromosoma (1977) 1.10
Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc Natl Acad Sci U S A (1984) 1.10
Alleviation of glucose repression of maltose metabolism by MIG1 disruption in Saccharomyces cerevisiae. Appl Environ Microbiol (1996) 1.10
Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg (2001) 1.08
Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology (1994) 1.08
Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem (1994) 1.07
One strand equivalent of the Escherichia coli genome is transcribed: complexity and abundance classes of mRNA. Science (1977) 1.07
The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem Hoppe Seyler (1995) 1.06
In vivo dynamics of galactose metabolism in Saccharomyces cerevisiae: metabolic fluxes and metabolite levels. Biotechnol Bioeng (2001) 1.05
Investigation of the impact of MIG1 and MIG2 on the physiology of Saccharomyces cerevisiae. J Biotechnol (1999) 1.04
Insulinomimetic effect on glucose transport by epidermal growth factor when combined with a major histocompatibility complex class I-derived peptide. J Biol Chem (1993) 1.04
Possible roles of compound membrane receptors in the immune system. Ann Immunol (Paris) (1983) 1.03
The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood (1992) 1.03
Ability for anaerobic growth is not sufficient for development of the petite phenotype in Saccharomyces kluyveri. J Bacteriol (2001) 1.03
Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology. Prog Allergy (1985) 1.03
Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell (1990) 1.01
Organization of herpes simplex virus type 1 deoxyribonucleic acid during replication probed in living cells with 4,5',8-trimethylpsoralen. Biochemistry (1982) 1.01
N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem (1993) 1.00
Studies of DNA bound RNA molecules isolated from nucleoids of Escherichia coli. Nucleic Acids Res (1976) 1.00
Torsional tension in intracellular bacteriophage T4 DNA. Evidence that a linear DNA duplex can be supercoiled in vivo. J Mol Biol (1982) 1.00
Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem (1993) 1.00
The impact of GAL6, GAL80, and MIG1 on glucose control of the GAL system in Saccharomyces cerevisiae. FEMS Yeast Res (2001) 0.99
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J (1991) 0.99
Fermentation performance and intracellular metabolite patterns in laboratory and industrial xylose-fermenting Saccharomyces cerevisiae. Appl Microbiol Biotechnol (2002) 0.98
Carbon catabolite repression of invertase during batch cultivations of Saccharomyces cerevisiae: the role of glucose, fructose, and mannose. Appl Microbiol Biotechnol (1998) 0.97
Adaptation of the xylose fermenting yeast Saccharomyces cerevisiae F12 for improving ethanol production in different fed-batch SSF processes. J Ind Microbiol Biotechnol (2010) 0.97
Regulation of ribosomal RNA synthesis in stringent bacteria. Nat New Biol (1971) 0.96
Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine, and thiopental. Anesthesiology (1981) 0.96
Antibody producing human-human hybridomas. I. Technical aspects. J Immunol Methods (1983) 0.95
Ordered and preferential initiation of ribosomal RNA synthesis in vitro. Nat New Biol (1972) 0.95
Inhibition of internalization of glucose transporters and IGF-II receptors. Mechanism of action of MHC class I-derived peptides which augment the insulin response in rat adipose cells. J Biol Chem (1993) 0.94
Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide. J Pharmacol Exp Ther (1993) 0.94
Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur J Biochem (1992) 0.94
Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice. Genes Immun (2005) 0.94
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest (1993) 0.94
Adjustable computerized stereotaxic brain atlas for transmission and emission tomography. AJNR Am J Neuroradiol (1983) 0.94
Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood (1990) 0.93
Derepression of galactose metabolism in melibiase producing bakers' and distillers' yeast. J Biotechnol (1999) 0.93
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem (1991) 0.93
Limb development in a "nonmodel" vertebrate, the direct-developing frog Eleutherodactylus coqui. J Exp Zool (2001) 0.92
Survival in small cell lung carcinoma after surgery. Thorax (1986) 0.91
Non-specific binding of protein-stabilized gold sols as a source of error in immunocytochemistry. Eur J Cell Biol (1986) 0.91